What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 1 minute read Pharma Industry News MindMed completes Phase 2b trial enrollment for MM-120 in GAD treatment MindMed Inc., a clinical-stage biopharmaceutical company, has announced the completion of enrollment and dosing in its Phase 2b… byPallavi MadhirajuSeptember 12, 2023